scholarly article | Q13442814 |
P50 | author | Chun Li | Q64183498 |
P2093 | author name string | Annette Oeser | |
C Michael Stein | |||
Cecilia P Chung | |||
Young Hee Rho | |||
Jeffrey R Smith | |||
Kevin M Bradley | |||
Vivian K Kawai | |||
Joseph F Solus | |||
P2860 | cites work | Regulation of immunity and oncogenesis by the IRF transcription factor family | Q24293755 |
The nuclear isoform of protein-tyrosine phosphatase TC-PTP regulates interleukin-6-mediated signaling pathway through STAT3 dephosphorylation | Q24308062 | ||
A large-scale replication study identifies TNIP1, PRDM1, JAZF1, UHRF1BP1 and IL10 as risk loci for systemic lupus erythematosus | Q24629130 | ||
The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 | ||
Cytokines in the pathogenesis of rheumatoid arthritis | Q28303865 | ||
The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage | Q30301191 | ||
Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis | Q30423162 | ||
The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations | Q30495275 | ||
Increased susceptibility to dextran sulfate sodium induced colitis in the T cell protein tyrosine phosphatase heterozygous mouse | Q33527394 | ||
Protection of epithelial barrier function by the Crohn's disease associated gene protein tyrosine phosphatase n2 | Q33793839 | ||
Interferon regulatory factor 5 is critical for the development of lupus in MRL/lpr mice. | Q43538775 | ||
Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE. | Q44441787 | ||
Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptide-induced cytokine secretion and autophagy. | Q45159554 | ||
Systemic lupus erythematosus. | Q53202066 | ||
Rheumatoid arthritis | Q56656479 | ||
Gene-Centric Analysis Identifies Variants Associated With Interleukin-6 Levels and Shared Pathways With Other Inflammation Markers | Q57315388 | ||
Murine dendritic cell type I IFN production induced by human IgG-RNA immune complexes is IFN regulatory factor (IRF)5 and IRF7 dependent and is required for IL-6 production | Q80358480 | ||
Increased coronary-artery atherosclerosis in rheumatoid arthritis: relationship to disease duration and cardiovascular risk factors | Q81300622 | ||
Lymphoid tyrosine phosphatase and autoimmunity: human genetics rediscovers tyrosine phosphatases | Q33895460 | ||
Adipocytokines are associated with radiographic joint damage in rheumatoid arthritis. | Q33950766 | ||
Premature coronary-artery atherosclerosis in systemic lupus erythematosus | Q33974685 | ||
Why is PTPN22 a good candidate susceptibility gene for autoimmune disease? | Q34026657 | ||
Signal transduction by tumor necrosis factor and gene regulation of the inflammatory cytokine interleukin-6. | Q34047262 | ||
Association of NCF2, IKZF1, IRF8, IFIH1, and TYK2 with systemic lupus erythematosus | Q34064253 | ||
A comprehensive analysis of shared loci between systemic lupus erythematosus (SLE) and sixteen autoimmune diseases reveals limited genetic overlap | Q34102802 | ||
A targeted association study in systemic lupus erythematosus identifies multiple susceptibility alleles | Q34144851 | ||
Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis | Q34250412 | ||
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis | Q34315745 | ||
Genetic variants in genes of the inflammatory response in association with infective endocarditis | Q34316847 | ||
Macrophage activation and coronary atherosclerosis in systemic lupus erythematosus and rheumatoid arthritis | Q34486477 | ||
Study of the common genetic background for rheumatoid arthritis and systemic lupus erythematosus | Q34551268 | ||
Association of a functional IRF7 variant with systemic lupus erythematosus | Q34713529 | ||
NOD-like receptors: role in innate immunity and inflammatory disease | Q34858900 | ||
Genetic variants and disease-associated factors contribute to enhanced interferon regulatory factor 5 expression in blood cells of patients with systemic lupus erythematosus | Q35542816 | ||
Phenotypic associations of genetic susceptibility loci in systemic lupus erythematosus | Q35596715 | ||
Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression | Q35652186 | ||
Involvement of the small protein tyrosine phosphatases TC-PTP and PTP1B in signal transduction and diseases: from diabetes, obesity to cell cycle, and cancer | Q36274061 | ||
Novel cardiovascular risk factors in premature coronary atherosclerosis associated with systemic lupus erythematosus. | Q36952629 | ||
Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets | Q37131055 | ||
No Association between Circulating Levels and Genetic Variants of IL-6 and TNF-α and Colon Adenoma | Q37301211 | ||
Detecting shared pathogenesis from the shared genetics of immune-related diseases | Q37353862 | ||
Inflammation-associated insulin resistance: differential effects in rheumatoid arthritis and systemic lupus erythematosus define potential mechanisms | Q37371379 | ||
T-cell protein tyrosine phosphatase is a key regulator in immune cell signaling: lessons from the knockout mouse model and implications in human disease | Q37416284 | ||
Autoimmunity risk alleles in costimulation pathways | Q37474977 | ||
Toxicological disruption of signaling homeostasis: tyrosine phosphatases as targets | Q37670217 | ||
Cytokines and their roles in the pathogenesis of systemic lupus erythematosus: from basics to recent advances | Q37751877 | ||
New IBD genetics: common pathways with other diseases. | Q37837253 | ||
Pathophysiology of rheumatoid arthritis | Q37856146 | ||
Genomics and the multifactorial nature of human autoimmune disease | Q37949708 | ||
Therapeutic applications of macrophage colony-stimulating factor-1 (CSF-1) and antagonists of CSF-1 receptor (CSF-1R) signaling. | Q37970302 | ||
IL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential | Q37983096 | ||
Inflammatory mechanisms in atherosclerosis: the impact of matrix metalloproteinases. | Q38004039 | ||
PPARγ expression is increased in systemic lupus erythematosus patients and represses CD40/CD40L signaling pathway. | Q39574464 | ||
New classification of HLA-DRB1 alleles supports the shared epitope hypothesis of rheumatoid arthritis susceptibility | Q42653008 | ||
P433 | issue | 8 | |
P921 | main subject | systemic lupus erythematosus | Q1485 |
rheumatoid arthritis | Q187255 | ||
serum concentration | Q126107668 | ||
P304 | page(s) | 1375-1382 | |
P577 | publication date | 2015-02-05 | |
P1433 | published in | Clinical Rheumatology | Q15754927 |
P1476 | title | Genetics of serum concentration of IL-6 and TNFα in systemic lupus erythematosus and rheumatoid arthritis: a candidate gene analysis | |
P478 | volume | 34 |